Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Single Volume 1H MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00184288
|Norwegian University of Science and Technology, Faculty of Medicine|
|Trondheim, Norway, N-7489|
|Study Director:||Steinar Lundgren, MD PhD||Cancer clinic, St.Olavs Hospital Trondheim University Hospital|